TR200101664T2 - Fenilendiamin grubu i‡eren herpesviruslarìn heteroksiklik karboksamid i‡eren tiore inhibit”rleri - Google Patents

Fenilendiamin grubu i‡eren herpesviruslarìn heteroksiklik karboksamid i‡eren tiore inhibit”rleri

Info

Publication number
TR200101664T2
TR200101664T2 TR2001/01664T TR200101664T TR200101664T2 TR 200101664 T2 TR200101664 T2 TR 200101664T2 TR 2001/01664 T TR2001/01664 T TR 2001/01664T TR 200101664 T TR200101664 T TR 200101664T TR 200101664 T2 TR200101664 T2 TR 200101664T2
Authority
TR
Turkey
Prior art keywords
carbon atoms
inhibitors
herpesviruses
thio
heterocyclic carboxamide
Prior art date
Application number
TR2001/01664T
Other languages
English (en)
Turkish (tr)
Inventor
David Bloom Jonathan
Joseph Curran Kevin
Joseph Digrandi Martin
George Dushin Rusell
Richard Jones Thomas
Albert Lang Stanley
Antonia Ross Adma
Anthony Terefenko Eugene
Mark O'hara Bryan
Original Assignee
American Home Products Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corporation filed Critical American Home Products Corporation
Publication of TR200101664T2 publication Critical patent/TR200101664T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/061,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2001/01664T 1998-12-09 1999-12-06 Fenilendiamin grubu i‡eren herpesviruslarìn heteroksiklik karboksamid i‡eren tiore inhibit”rleri TR200101664T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20855998A 1998-12-09 1998-12-09

Publications (1)

Publication Number Publication Date
TR200101664T2 true TR200101664T2 (tr) 2002-03-21

Family

ID=22775044

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01664T TR200101664T2 (tr) 1998-12-09 1999-12-06 Fenilendiamin grubu i‡eren herpesviruslarìn heteroksiklik karboksamid i‡eren tiore inhibit”rleri

Country Status (18)

Country Link
EP (1) EP1144397A3 (cs)
JP (1) JP2002531554A (cs)
CN (1) CN1348446A (cs)
AU (1) AU1934700A (cs)
BG (1) BG105581A (cs)
BR (1) BR9916046A (cs)
CA (1) CA2350767A1 (cs)
CZ (1) CZ20011956A3 (cs)
EA (1) EA200100631A1 (cs)
HU (1) HUP0200232A2 (cs)
ID (1) ID30158A (cs)
IL (1) IL143182A0 (cs)
NO (1) NO20012832L (cs)
PL (1) PL349217A1 (cs)
SK (1) SK7682001A3 (cs)
TR (1) TR200101664T2 (cs)
WO (1) WO2000034258A2 (cs)
ZA (1) ZA200104377B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6166028A (en) * 1998-12-09 2000-12-26 American Home Products Corporation Diaminopuridine-containing thiourea inhibitors of herpes viruses
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
ATE311366T1 (de) 2000-02-29 2005-12-15 Millennium Pharm Inc Benzamide und ähnliche inhibitoren vom faktor xa
US7220768B2 (en) * 2003-02-11 2007-05-22 Wyeth Holdings Corp. Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
PT2077995E (pt) 2006-11-02 2012-05-10 Millennium Pharm Inc Métodos de sintetizar sais farmacêuticos de um inibidor de fator xa
WO2014070979A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
WO2014070978A1 (en) * 2012-11-03 2014-05-08 Boehringer Ingelheim International Gmbh Inhibitors of cytomegalovirus
CN110565100B (zh) * 2019-07-12 2021-05-07 西北工业大学 一种二茂钴阳离子基缓蚀剂及制备方法和使用方法
WO2023011574A1 (zh) 2021-08-05 2023-02-09 浙江海正药业股份有限公司 芳香乙炔类衍生物及其制备方法和用途
EP4433479A1 (en) 2021-11-19 2024-09-25 Basf Se Bicyclic compounds for the control of invertebrate pests
CN115433093A (zh) * 2022-09-26 2022-12-06 无锡双启科技有限公司 一种3-氯-4-三氟甲基苯胺的制备方法
CN115710190A (zh) * 2022-11-16 2023-02-24 常州佳德医药科技有限公司 4-甲氧基-2-氨基-n,n-二甲基苯胺、制备方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE298741T1 (de) * 1997-04-10 2005-07-15 Pharmacia & Upjohn Co Llc Polyaromatische verbindungen zur behandlung von herpes-infektionen

Also Published As

Publication number Publication date
EP1144397A2 (en) 2001-10-17
HUP0200232A2 (hu) 2002-05-29
WO2000034258A3 (en) 2001-11-29
WO2000034258A2 (en) 2000-06-15
PL349217A1 (en) 2002-07-01
CA2350767A1 (en) 2000-06-15
CZ20011956A3 (cs) 2001-10-17
JP2002531554A (ja) 2002-09-24
EP1144397A3 (en) 2002-09-11
NO20012832D0 (no) 2001-06-08
BG105581A (en) 2001-12-31
SK7682001A3 (en) 2002-07-02
ZA200104377B (en) 2002-12-20
IL143182A0 (en) 2002-04-21
ID30158A (id) 2001-11-08
NO20012832L (no) 2001-08-07
EA200100631A1 (ru) 2002-02-28
BR9916046A (pt) 2001-10-02
AU1934700A (en) 2000-06-26
CN1348446A (zh) 2002-05-08

Similar Documents

Publication Publication Date Title
TR200101664T2 (tr) Fenilendiamin grubu i‡eren herpesviruslarìn heteroksiklik karboksamid i‡eren tiore inhibit”rleri
EP1046391A3 (de) Verwendung von aminosubstituierten Hydroxybenzophenonen als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen
IL99755A0 (en) Hydroxymethyl(methylenecyclopentyl)purines and pyrimidines and pharmaceutical compositions containing the same
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
PT1021405E (pt) Derivados de azetidinona para o tratamento de infeccoes de hcmv
PT91575A (pt) Procede de preparation de benzylamines disubstituees utiles comme medicaments
WO2000034261A3 (en) Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
WO2000034237A3 (en) Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
IL107356A0 (en) Antiretroviral acyl compounds
DE69731483D1 (de) Beta-l-dioxolanuridin-analoge zur behandlung und vorbeugung von durch ebv, vzv bzw. hv-8 verursachten viralen infektionen
CA2301967A1 (en) Azetidinone derivatives for the treatment of hcmv infections
PH31682A (en) 4-Iminoquinolines, process for their preparation, and their use.
EA200100635A1 (ru) Производные тиомочевины в качестве ингибиторов вирусов герпеса
IL60443A (en) 2,2-dichlorocyclopropyl-methylphosphoric acid derivatives,their preparation and their use in combating pests
DK0379414T3 (da) Derivater af 1,8-benzonaphthyridin og fremstilling deraf
PT1120415E (pt) Compostos de isoxazoliltiofeno substituido
DE59915244D1 (de) Kosmetische oder pharmazeutische Zubereitungen enthaltend 1,3,5-Triazinderivate und Zinkoxid
DK96086D0 (da) 8-thiotetrahydroquinolinderivater, deres fremstilling og anvendelsesom laegemidler
ES2154191A1 (es) Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.